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Introduction
Juvenile Idiopathic Arthritis (JIA) is classified as an
acquired autoinflammatory disease. Problems in apply-
ing all classification criteria include the necessity to
exclude other diseases with similar symptoms. There are
no laboratory markers for sJIA.
Objectives
To analyze cases with cancer diagnosis who were in
rheumatology department in SCCH of RAMS.
Methods
13 patients were included in the analysis. All Patients
were directed (referred) to our clinic like patients who
were suffered from JIA from 2004 to 2014 years. We ana-
lyzed time concomitant therapy, symptoms of diseases,
cancer diagnosis, diagnostic methods which helped to
exclude JIA.
Results
11 patients were directed with systemic JIA and 2 - with
olygoarthritis. All patients with “JIA” had criteria for
diagnosis according ILAR classification. All patients with
‘’systemic JIA’’ had fever, hepatosplenomegaly, general-
ized lymphadenopathy, arthralgia or arthritis, high level
of CRP, ESR, anemia. Patients with ‘’óligoarthritis’’ had
monoarthritis. The diagnosis was made at the place of
residence. 6 patients received immunodepressants (meth-
otrexate, cyclosporine), 8 patients – glucocoticoids, 1 –
tocilizumab. Disease duration was from 2 to 9 months,
the duration of hospitalization until the diagnosis was
verified was from 1 to 7 days. We performed ultrasound,
radiography, CT scan, MRI, bone marrow punction,
biopsy of lymph node, biopsy of bone. There were 4
patients with neuroblastoma, 2 - with lymphogranuloma-
tosis, 4 - with leukemia, 1- with malignant lymphoma
from patients with “sJIA”. There was 1 patient with
malignant histiocytoma and 1 patient with glyoma from
patients with “oligoarthritis”. Concomitant treatment
made difficult to verify right diagnosis.
Conclusion
JIA is still a diagnosis of exclusion. We should use mod-
ern diagnostic procedures to establish right diagnosis and
mustn’t give antirheumatic drugs except NSAID to our
patients until the diagnosis is verified.
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